NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023
- PMID: 37433432
- DOI: 10.6004/jnccn.2023.0035
NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023
Abstract
In 2023, the NCCN Guidelines for Hepatobiliary Cancers were divided into 2 separate guidelines: Hepatocellular Carcinoma and Biliary Tract Cancers. The NCCN Guidelines for Biliary Tract Cancers provide recommendations for the evaluation and comprehensive care of patients with gallbladder cancer, intrahepatic cholangiocarcinoma, and extrahepatic cholangiocarcinoma. The multidisciplinary panel of experts meets at least on an annual basis to review requests from internal and external entities as well as to evaluate new data on current and emerging therapies. These Guidelines Insights focus on some of the recent updates to the NCCN Guidelines for Biliary Tract Cancers as well as the newly published section on principles of molecular testing.
Similar articles
-
Modification and implementation of NCCN guidelines on hepatobiliary cancers in the Middle East and North Africa region.J Natl Compr Canc Netw. 2010 Jul;8 Suppl 3:S36-40. doi: 10.6004/jnccn.2010.0123. J Natl Compr Canc Netw. 2010. PMID: 20697130
-
Biliary tract cancer.Eur J Surg Oncol. 2025 Jun;51(6):108489. doi: 10.1016/j.ejso.2024.108489. Epub 2024 Jun 15. Eur J Surg Oncol. 2025. PMID: 38902180 Review.
-
Hepatobiliary cancers, version 2.2014.J Natl Compr Canc Netw. 2014 Aug;12(8):1152-82. doi: 10.6004/jnccn.2014.0112. J Natl Compr Canc Netw. 2014. PMID: 25099447
-
Biliary tract cancer.Cancer Treat Res. 1997;90:273-307. doi: 10.1007/978-1-4615-6165-1_15. Cancer Treat Res. 1997. PMID: 9367089 Review. No abstract available.
-
[Clinical relevance of the new S3 guideline on hepatocellular carcinoma and biliary tract cancer for practitioners].Radiologe. 2022 Mar;62(3):200-204. doi: 10.1007/s00117-022-00970-3. Epub 2022 Feb 11. Radiologe. 2022. PMID: 35147708 Review. German.
Cited by
-
Chemotherapy combined with regorafenib and immune checkpoint inhibitors as a first-line treatment for patients with advanced biliary tract cancer: a single arm phase II trial.Front Immunol. 2024 Sep 18;15:1449211. doi: 10.3389/fimmu.2024.1449211. eCollection 2024. Front Immunol. 2024. PMID: 39359732 Free PMC article. Clinical Trial.
-
Molecular Targeting of the Human Epidermal Growth Factor Receptor-2 (HER2) Genes across Various Cancers.Int J Mol Sci. 2024 Jan 15;25(2):1064. doi: 10.3390/ijms25021064. Int J Mol Sci. 2024. PMID: 38256137 Free PMC article. Review.
-
Clinical management of intrahepatic cholangiocarcinoma: surgical approaches and systemic therapies.Front Oncol. 2024 Jan 24;14:1321683. doi: 10.3389/fonc.2024.1321683. eCollection 2024. Front Oncol. 2024. PMID: 38344197 Free PMC article. Review.
-
Treatment options for biliary tract cancer: unmet needs, new targets and opportunities from both physicians' and patients' perspectives.Future Oncol. 2024;20(20):1435-1450. doi: 10.1080/14796694.2024.2340959. Epub 2024 May 30. Future Oncol. 2024. PMID: 38861288 Free PMC article. Review.
-
Detecting Early Recurrence With Circulating Tumor DNA in Stage I-III Biliary Tract Cancer After Curative Resection.JCO Precis Oncol. 2025 Jan;9:e2400443. doi: 10.1200/PO-24-00443. Epub 2025 Jan 7. JCO Precis Oncol. 2025. PMID: 39772829
MeSH terms
LinkOut - more resources
Full Text Sources
Medical